Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03289208
What this trial is testing

Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment

Who this might be right for
Renal ImpairmentHealthy
Shionogi 30
Post-approval studies (Phase 4)Ended earlyNCT00495365
What this trial is testing

A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease.

Who this might be right for
AnemiaChronic Renal Insufficiency
Ortho Biotech Products, L.P. 8
Testing effectiveness (Phase 2)WithdrawnNCT01453634
What this trial is testing

Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018)

Who this might be right for
Stage 5 Chronic Kidney Disease (CKD)Secondary Hyperparathyroidism (SHPT)Hemodialysis (HD)
OPKO Health, Inc.
Post-approval studies (Phase 4)Looking for participantsNCT05515367
What this trial is testing

A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)

Who this might be right for
Chronic Kidney DiseasesAnemia of Chronic Kidney Disease
Zydus Lifesciences Limited 1,004
Large-scale testing (Phase 3)Study completedNCT02268994
What this trial is testing

KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD

Who this might be right for
Anemia of Chronic Kidney Disease
Keryx Biopharmaceuticals 234
Testing effectiveness (Phase 2)UnknownNCT06398002
What this trial is testing

The Effect of Increasing Dialysate Calcium on T50 in Subjects With Secondary Hyperparathyroidism and ESKD

Who this might be right for
Secondary HyperparathyroidismEnd-stage Kidney Disease
Iain Bressendorff 48
Large-scale testing (Phase 3)Study completedNCT00663260
What this trial is testing

Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 631
Early research (Phase 1)Study completedNCT04510090
What this trial is testing

Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus

Who this might be right for
PruritusCholestasisKidney Failure
Escient Pharmaceuticals, Inc 89
Large-scale testing (Phase 3)Study completedNCT00994318
What this trial is testing

Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)

Who this might be right for
Iron Deficiency AnaemiaChronic Kidney Disease
Vifor Pharma 626
Large-scale testing (Phase 3)WithdrawnNCT05082571
What this trial is testing

Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease

Who this might be right for
Anemia of Chronic Kidney Disease
Akebia Therapeutics
Early research (Phase 1)Study completedNCT02040597
What this trial is testing

Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment.

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Chiesi Farmaceutici S.p.A. 42
Early research (Phase 1)Study completedNCT01028768
What this trial is testing

Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal Function

Who this might be right for
Renal Impairment
Nycomed 36
Testing effectiveness (Phase 2)Study completedNCT02836574
What this trial is testing

Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Prokidney 83
Early research (Phase 1)Study completedNCT01984723
What this trial is testing

EVP-6124 Renal Impairment Study

Who this might be right for
Renal Impairment
FORUM Pharmaceuticals Inc 32
Early research (Phase 1)Study completedNCT07347808
What this trial is testing

A Pharmacokinetic Study of VCT220 With Moderate Renal Impairment Patients

Who this might be right for
Obesity & Overweight
Vincentage Pharma Co., Ltd 16
Early research (Phase 1)Study completedNCT00585143
What this trial is testing

Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly

Who this might be right for
Dyslipidemia, Renal Insufficiency
AstraZeneca 37
Early research (Phase 1)Ended earlyNCT01957657
What this trial is testing

Pharmacokinetics, Safety and Tolerability of the Combination of BI 207127 and Faldaprevir in Renal Impaired Patients

Who this might be right for
Renal Insufficiency
Boehringer Ingelheim 4
Early research (Phase 1)Study completedNCT02354937
What this trial is testing

Pharmacokinetics Study of GSK1265744 in Subjects With Severe Renal Impairment

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 16
Early research (Phase 1)Study completedNCT01568775
What this trial is testing

Pharmacokinetics, Safety and Tolerability of Aliskiren (SPP100) in Patients With End Stage Renal Disease on Hemodialysis and Matched Healthy Subjects

Who this might be right for
End Stage Renal Disease
Novartis 12
Early research (Phase 1)Study completedNCT06246175
What this trial is testing

HRS9531 in Participants With Impaired Kidney Function and Healthy Subjects

Who this might be right for
Type 2 Diabetes
Fujian Shengdi Pharmaceutical Co., Ltd. 32
Next Page